The rising cost of drugs and how to address it
CTL019 in pediatric and young adult relapsed/refractory acute lymphoblastic leukemia (ALL) patients
What impact do side effects have on elderly chronic myeloid leukemia (CML) patients?
Biosimilars - the question of trials and approval
Clinical evidence supporting rituximab
Won Seog Kim